Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Natalia, Alkon"'
Autor:
Christine Bangert, Natalia Alkon, Sumanth Chennareddy, Tamara Arnoldner, Jasmine P. Levine, Magdalena Pilz, Marco A. Medjimorec, John Ruggiero, Emry R. Cohenour, Constanze Jonak, William Damsky, Johannes Griss, Patrick M. Brunner
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-18 (2024)
Abstract Dupilumab, an IL4R-blocking antibody, has shown clinical efficacy for atopic dermatitis (AD) treatment. In addition to conjunctivitis/blepharitis, the de novo appearance of head/neck dermatitis is now recognized as a distinct side effect, oc
Externí odkaz:
https://doaj.org/article/12efcd22a49d40dc80a5be875cc9f9e7
Autor:
Katharina Rindler, Constanze Jonak, Natalia Alkon, Felix M. Thaler, Harald Kurz, Lisa E. Shaw, Georg Stingl, Wolfgang Weninger, Florian Halbritter, Wolfgang M. Bauer, Matthias Farlik, Patrick M. Brunner
Publikováno v:
Molecular Cancer, Vol 20, Iss 1, Pp 1-23 (2021)
Abstract Background In early-stage mycosis fungoides (MF), the most common primary cutaneous T-cell lymphoma, limited skin involvement with patches and plaques is associated with a favorable prognosis. Nevertheless, approximately 20–30% of cases pr
Externí odkaz:
https://doaj.org/article/2720d6bc4c23482a912b316fd2254e83
Autor:
Katharina Rindler, Thomas Krausgruber, Felix M. Thaler, Natalia Alkon, Christine Bangert, Harald Kurz, Nikolaus Fortelny, Thomas B. Rojahn, Constanze Jonak, Johannes Griss, Christoph Bock, Patrick M. Brunner
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Atopic dermatitis (AD) typically starts in infancy or early childhood, showing spontaneous remission in a subset of patients, while others develop lifelong disease. Despite an increased understanding of AD, factors guiding its natural course are only
Externí odkaz:
https://doaj.org/article/7ebd1a2d949c462ead9927729487aa7a
Autor:
Natalia Alkon, Frank P. Assen, Tamara Arnoldner, Wolfgang M. Bauer, Marco A. Medjimorec, Lisa E. Shaw, Katharina Rindler, Gregor Holzer, Philipp Weber, Wolfgang Weninger, Christian Freystätter, Sumanth Chennareddy, Tamar Kinaciyan, Matthias Farlik, Constanze Jonak, Johannes Griss, Christine Bangert, Patrick M. Brunner
Publikováno v:
Journal of Allergy and Clinical Immunology.
Autor:
Natalia Alkon
Publikováno v:
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDGLiteratur. 20(10)
Autor:
Katharina Rindler, Lisa E. Shaw, Franz Trautinger, Thomas B. Rojahn, Lorenzo Cerroni, Wolfgang Weninger, Georg Stingl, Philipp Tschandl, Natalia Alkon, Patrick M. Brunner, Constanze Jonak, Stefanie Porkert, Matthias Farlik
Publikováno v:
British Journal of Dermatology. 185:1013-1025
BACKGROUND Primary cutaneous lymphomas comprise a heterogeneous group of B-cell and T-cell malignancies which often show an indolent course, but can progress to aggressive disease in a subset of patients. Diagnosis is often delayed owing to clinical
Autor:
Patrick Brunner, Constanze Jonak, Matthias Farlik, Johannes Griss, Wolfgang Weninger, Julia Valencak, Ulrike Mann, Lisa Shaw, Mathias Drach, Natalia Alkon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e4a6eb3c314dca995c7acc2e6fc0240
https://doi.org/10.26226/m.62fa00a04b6034001b1c315c
https://doi.org/10.26226/m.62fa00a04b6034001b1c315c
Autor:
Tamara Quint, Johannes Griss, Adelheid Elbe-Bürger, Felix M. Thaler, Thomas Krausgruber, Nikolaus Fortelny, Harald Kurz, Natalia Alkon, Christoph Bock, Wolfgang Bauer, Constanze Jonak, Vera Vorstandlechner, Katharina Rindler, Michael Mildner, Patrick M. Brunner, Christine Bangert, Denis Demirtas, Tanya Ayub
Publikováno v:
Science Immunology. 6
Therapeutic options for autoimmune diseases typically consist of broad and targeted immunosuppressive agents. However, sustained clinical benefit is rarely achieved, as the disease phenotype usually returns after cessation of treatment. To better und
Autor:
Christine, Bangert, Katharina, Rindler, Thomas, Krausgruber, Natalia, Alkon, Felix M, Thaler, Harald, Kurz, Tanya, Ayub, Denis, Demirtas, Nikolaus, Fortelny, Vera, Vorstandlechner, Wolfgang M, Bauer, Tamara, Quint, Michael, Mildner, Constanze, Jonak, Adelheid, Elbe-Bürger, Johannes, Griss, Christoph, Bock, Patrick M, Brunner
Publikováno v:
Science immunology. 6(55)
Therapeutic options for autoimmune diseases typically consist of broad and targeted immunosuppressive agents. However, sustained clinical benefit is rarely achieved, as the disease phenotype usually returns after cessation of treatment. To better und